A Therapeutic System of 177Lu-labeled Gold Nanoparticles-RGD Internalized in Breast Cancer Cells

被引：0
|
作者：
Luna-Gutierrez, Myrna [1 ,2 ]
Ferro-Flores, Guillermina [1 ]
Ocampo-Garcia, Blanca E. [1 ]
Santos-Cuevas, Clara L. [1 ]
Jimenez-Mancilla, Nallely [1 ,2 ]
De Leon-Rodriguez, L. M. [3 ]
Azorin-Vega, Erika [1 ]
Isaac-Olive, Keila [2 ]
机构：
[1] Inst Nacl Invest Nucl, Dept Mat Radiactivos, Toluca, Estado De Mexic, Mexico
[2] Univ Autonoma Estado Mexico, Fac Med, Toluca, Estado De Mexic, Mexico
[3] Univ Guanajuato, Dept Quim, Guanajuato, Mexico
来源：
JOURNAL OF THE MEXICAN CHEMICAL SOCIETY | 2013年 / 57卷 / 03期
关键词：
gold nanoparticles; radiolabeled nanoparticles; radio-gold nanoparticles; radiolabeled peptides; nanoparticle-peptide; RGD peptide; lutetium-177; IN-VITRO; PEPTIDES; LIGANDS;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The aim of this research was to evaluate the in vitro potential of Lu-177-labeled gold nanoparticles conjugated to cyclo-[RGDfK(C)] peptides (Lu-177-AuNP-c[RGDfK(C)]) as a plasmonic photothermal therapy and targeted radiotherapy system in MCF7 breast cancer cells. Peptides were conjugated to AuNPs (20 nm) by spontaneous reaction with the thiol group of cysteine (C). After laser irradiation, the presence of c[RGDfK(C)]-AuNP in cells caused a significant increase in the temperature of the medium (50.5 C, compared to 40.3 C without AuNPs) resulting in a significant decrease in MCF7 cell viability down to 9 %. After treatment with Lu-177-AuNP-c[RGDfK(C)], the MCF7 cell proliferation was significantly inhibited.
引用
收藏
页码：212 / 219
页数：8
相关论文
共 50 条
  • [1] Smaller Agents for Larger Therapeutic Indices: Nanoscale Brachytherapy with 177Lu-Labeled Gold Nanoparticles
    Ehlerding, Emily B.
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 834 - 835
  • [2] Development of a 177Lu-Labeled RGD Derivative for Targeting Angiogenesis
    Ju, Chang Hwan
    Jeong, Jae Min
    Lee, Yun-Sang
    Kim, Young Joo
    Lee, Byung Chul
    Lee, Dong Soo
    Chung, June-Key
    Lee, Myung Chul
    Jeong, Seo Young
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2010, 25 (06) : 687 - 691
  • [3] Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer
    Yook, Simmyung
    Cai, Zhongli
    Lu, Yijie
    Winnik, Mitchell A.
    Pignol, Jean-Philippe
    Reilly, Raymond M.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 936 - 942
  • [4] Engineering of 177Lu-labeled gold encapsulated into dendrimeric nanomaterials for the treatment of lung cancer
    Wang, Zheng
    Ye, Minhua
    Ma, Dehua
    Shen, Jianfei
    Fang, Fang
    JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2022, 33 (02) : 197 - 211
  • [5] 177Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer
    Salvanou, Evangelia-Alexandra
    Kolokithas-Ntoukas, Argiris
    Prokopiou, Danai
    Theodosiou, Maria
    Efthimiadou, Eleni
    Kozminski, Przemyslaw
    Xanthopoulos, Stavros
    Avgoustakis, Konstantinos
    Bouziotis, Penelope
    MOLECULES, 2024, 29 (05):
  • [6] Potentials of 177Lu-labeled sodium pyrophosphate (177Lu-PYP) as a new therapeutic radiopharmaceutical for the treatment of bone cancer
    Abbasi, Imtiaz Ahmed
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [7] Bioinspired Synthesis of Intrinsically 177Lu-Labeled Hybrid Nanoparticles for Potential Cancer Therapy
    Chakravarty, Rubel
    Guleria, Apurav
    Jadhav, Sachin
    Kumar, Chandan
    Debnath, Anil Krishna
    Sarma, Haladhar Dev
    Chakraborty, Sudipta
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2020, 59 (52) : 22492 - 22500
  • [8] 177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinoma
    Jiang, Lei
    Miao, Zheng
    Liu, Hongguang
    Ren, Gang
    Bao, Ande
    Cutler, Cathy S.
    Shi, Hongcheng
    Cheng, Zhen
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (09) : 909 - 914
  • [9] Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer
    Qi Yang
    Zhao Chen
    Yongkang Qiu
    Wenpeng Huang
    Tianyao Wang
    Lele Song
    Xinyao Sun
    Cuicui Li
    Xiaojie Xu
    Lei Kang
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1246 - 1260
  • [10] Comparative cytotoxicity of 177Lu on various lung cancer cells and in vivo targeting of 177Lu-labeled cetuximab
    Li, Kehong
    Fan, Wenqi
    Yan, Jingxuan
    Wang, Jing
    Zhao, Peng
    Liao, Wei
    Yang, Yuchuan
    Yang, Xia
    Wei, Hongyuan
    Chen, Yue
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2023, 332 (06) : 2093 - 2102
12345